Medical/Pharmaceuticals
AGC Biologics Expands Partnership with Novavax
Manufacturing of Novavax' Matrix-M™Adjuvant for Novel COVID-19 Vaccine Expands toSeattle SEATTLE, Aug. 11, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it has expanded its partnership withNovavax, Inc. (NASDA...
2020-08-11 04:20
6872
New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution
Zero-loss energy filters enable life scientists to view protein structures in unprecedented detail HILLSBORO, Oregon, Aug. 11, 2020 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Im...
2020-08-11 04:17
3834
PHC Holdings Corporation and Ascensia Diabetes Care Announce Financing Agreement and Exclusive Global Commercial Agreement With Senseonics
TOKYO and BASEL, Switzerland, Aug. 11, 2020 /PRNewswire/ -- PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, today announced a strategic partnership with Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of long-term,...
2020-08-11 04:02
3610
Global Fund Launches Search for Inspector General
GENEVA, Aug. 11, 2020 /PRNewswire/ -- The Global Fund to Fight AIDS, Tuberculosis and Malaria has launched a search for its next Inspector General. A seven-member nomination committee will help the Board of the Global Fund select the next Inspector General. The Board welcomes all candidates with ...
2020-08-11 01:05
4036
miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology
- Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91% - Data Support Integration of Sentinel Prostate Test™ in Patient Care Settings and Decision-Making - Adoption Based on Published Data Indicates Hi...
2020-08-10 19:30
3366
First patient in treatment in RhoVac's clinical phase IIb study in the USA
STOCKHOLM, Aug. 10, 2020 /PRNewswire/ -- The first patient in the USA is included in RhoVac's clinical phase IIb study, called BRaVac. The first US clinic to include a patient in the study was Carolina Urologic Research Center. BraVac is a randomized, placebo controlled and double-blind study, wi...
2020-08-10 16:47
1968
AVATAMED Raises US$1 Million in Seed Funding
SINGAPORE, Aug. 10, 2020 /PRNewswire/ -- AVATAMED, a precision medicine company based inSingapore, announced the completion of its Seed round funding of US$1 million, led by Future Leading Bio Funds, along with other investors. Professor Pierce Chow, Senior Consultant at National Cancer Centre Si...
2020-08-10 15:27
3178
Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry
SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- On August 9th, 2020, Viva Biotech ( Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 80% of...
2020-08-10 08:00
4031
Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium
SUZHOU, China, Aug. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...
2020-08-08 21:00
17127
First hospitals in U.S. implant next-generation cardiac device to reduce risk of stroke
Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Los Robles Health System perform near simultaneous implantation ofWATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) AUSTIN, Texas, Aug. 8, 2020 /PRNewswire/ -- On Aug. 5, 2020, physicians at the Texas Cardiac Arrhythmia Institute ...
2020-08-08 10:08
5002
First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health's Guardant360® CDx, gains credibility among oncologists in Asia, Middle East and Africa.
SINGAPORE, Aug. 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Guardant Health's liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval r...
2020-08-08 03:21
5768
BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories, Countries and Regions
FRANKLIN LAKES, New Jersey, Aug. 7, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company,announced a voluntary recall onJune 23, 2020 for specified catalog numbers of the ChloraPrep™ 3 mL applicator due to possible fungal contamination, which only a...
2020-08-07 18:59
3703
Olympus announces acquisition of Arc Medical Design Limited from Norgine B.V.
TOKYO, Aug. 7, 2020 /PRNewswire/ -- Olympus Corporation today announced it has signed a definitive agreement to acquire Arc Medical Design Limited (Arc Medical Design), a subsidiary of Norgine B.V. The acquisition underscores Olympus' commitment to expanding its offering in gastrointestinal thera...
2020-08-07 14:00
3589
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG
SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalis...
2020-08-07 08:30
14084
Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine
Technology, expertise from UK's Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy SAN DIEGO, Aug. 7, 2020 /PRNewswire/ -- A biopharmaceutical company repurposing nafamostat, a generic remedy for pancreatitis and acute kidney injury, is one ...
2020-08-07 01:30
3995
Dietary cholesterol and phytosterols contribute directly to heart disease
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk REYKJAVIK, Iceland, Aug. 7, 2020 /PRNewswire/ -- Scientists at deCODE genetics , a subsidiary of Amgen, and their collaborators fromthe Icelandic healthcare system, University of Iceland, the Copenha...
2020-08-07 01:21
5650
The 23rd TDO® Software and 2nd GentleWave® User Meeting Moving to an All Virtual Experience
LAGUNA HILLS, California, Aug. 6, 2020 /PRNewswire/ -- Sonendo, Inc., a leading dental technology company, developer of theGentleWave System and the parent company of TDO Software Inc., the leading endodontic practice management software developer, announced today that its Annual TDO and GentleWa...
2020-08-06 20:32
3658
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development
Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer gl...
2020-08-06 20:10
2828
Tessa Therapeutics Announces Results from Two Independent Phase 1/2 Trials of Autologous CD30 CAR-T Cell Therapy in Patients with Relapsed or Refractory Hodgkin Lymphoma
SINGAPORE, Aug. 6, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a
clinical-stage cell therapy company developing next-generation cancer
treatments, today announced the publication of results in theJournal of
Clinical Oncology
2020-08-06 19:00
3100
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
SHANGHAI and DUNDALK, Ireland, Aug. 6, 2020 /PRNewswire/ -- WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr.Jian Dong as Chief Executive Officer (CEO). WuXi Vacci...
2020-08-06 17:00
3214
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6217
